Daewoong Pharmaceutical Co., Ltd. New York South Korea

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new global benchmarkView original content:https://www.prnewswire.co.uk/news-releases/daewoong-therapeutics-microneedle-patch-achieves-best-in-class-bioavailability-proving-the-strength-of-its-drug-delivery-platform-302528785.html